The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-18
SponsorThe University of Texas Health Science Center at San Antonio
About this trial
Scientists do research to answer important questions which might help change or improve the way we do things in the future.
The investigators know that using Enamel Matrix Derivatives results in thicker gum tissues around teeth. This study will test to see if using EMD around implants results in thicker gum tissues around implants.
Eligibility criteria
Qualifiers
Ability of subject to understand and the willingness to sign a written informed consent document.
Males and females; Age 18 to 89 years old
Require second stage implant uncovering
In either the maxillary or mandibular arch
Disqualifiers
Pregnancy, or those planning to become pregnant
Allergy or any medical issue using EMD
Non-English speaking
Patients on anticoagulants
Trial design
Treatments tested in this trial
- Enamel Matrix Derivative
Treatment groups
32 Participants
are divided into 2 treatment groupsLocations
1University of Texas Health Science Center at San Antonio78229, San AntonioTexas, United States
Sponsors and collaborators
The University of Texas Health Science Center at San Antonio
Lead sponsor
Source ClinicalTrials.gov